Lifestyle Tips

Getting used to JYNARQUE® (tolvaptan)

Lifestyle tips

Taking JYNARQUE may change the course of your disease by slowing the decline in kidney function. But it will likely mean some lifestyle changes. Here are some tips that might help you manage your treatment:

Speak up

  • Talk to your doctor to make sure you know exactly how to take JYNARQUE
  • Tell your whole healthcare team, including your healthcare providers and pharmacists, that you are taking JYNARQUE
  • If you feel comfortable, you may want to talk to people you know about your treatment, including the need for water and frequent bathroom visits

Keep to a schedule

  • Set a recurring event in your calendar to remind you when lab testing and other appointments are scheduled
  • Set alarms on your phone to help remind you when to take JYNARQUE
  • This chart may help you remember when to take your second dose

Make a plan

  • Download an app you can use to find nearby restrooms while traveling
  • Have some extra water containers handy—in the office, at home, and in the car
  • Make sure to urinate before meetings, dinner time, movies, or other social events

Talking to family

Talking about JYNARQUE® (tolvaptan)

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disease. You may want to talk about JYNARQUE with your family members

Sharing your experiences with JYNARQUE may help your family members

  • If you are comfortable talking to your family members about your ADPKD treatment plan, this information might help them understand what you're going through
  • Since ADPKD is an inherited disease, there might be other people in your family who have it. It might also help them to know the options available for adults living with ADPKD

COVID-19 UPDATE

With the COVID-19 situation constantly developing, your health is our top priority. We hope that you and your families are staying safe and healthy during this unprecedented time.

If you are currently taking JYNARQUE® (tolvaptan), we encourage you to stay in close contact with your healthcare professional team regarding regular appointments and treatment management plans.

At this time, there is no expected impact on medication supply.

During the current COVID-19 pandemic, the JYNARQUE® (tolvaptan) REMS Program requirements remain in effect, as the health of patients who use this product is our top priority. Ongoing blood monitoring required by the REMS Program is extremely important due to the potential risk of serious liver injury from treatment with JYNARQUE. For these lab requirements during COVID-19 pandemic, we are able to temporarily offer our Mobile Phlebotomy Collection Service at no-cost for all patients taking JYNARQUE who prefer to have the REMS required blood work collected at home.

In helping patients who have lost a job or health insurance coverage due to the COVID-19 pandemic and to get through these challenging times, we have extended our Patient Support Program to provide ‘no-cost’ access for patients in the U.S. who are taking JYNARQUE. Please call Otsuka Patient Support at 1-855-242-7787 for more information on both programs.

For help accessing JYNARQUE, go to www.otsukapatientsupport.com/jynarque or call Otsuka Patient Support at 1-855-242-7787. The nurses at Otsuka Patient Support can answer questions related to Product Accessibility, Reimbursement and connecting patients to local treatment sites in their community.

Please read FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE.

September 202010US20EBC0103

COVID-19 UPDATE

With the COVID-19 situation constantly developing, your health is our top priority. We hope that you and your families are staying safe and healthy during this unprecedented time.

If you are currently taking JYNARQUE® (tolvaptan), we encourage you to stay in close contact with your healthcare professional team regarding regular appointments and treatment management plans.

At this time, there is no expected impact on medication supply.

During the current COVID-19 pandemic, the JYNARQUE® (tolvaptan) REMS Program requirements remain in effect, as the health of patients who use this product is our top priority. Ongoing blood monitoring required by the REMS Program is extremely important due to the potential risk of serious liver injury from treatment with JYNARQUE. For these lab requirements during COVID-19 pandemic, we are able to temporarily offer our Mobile Phlebotomy Collection Service at no-cost for all patients taking JYNARQUE who prefer to have the REMS required blood work collected at home.

In helping patients who have lost a job or health insurance coverage due to the COVID-19 pandemic and to get through these challenging times, we have extended our Patient Support Program to provide ‘no-cost’ access for patients in the U.S. who are taking JYNARQUE. Please call Otsuka Patient Support at 1-855-242-7787 for more information on both programs.

For help accessing JYNARQUE, go to www.otsukapatientsupport.com/jynarque or call Otsuka Patient Support at 1-855-242-7787. The nurses at Otsuka Patient Support can answer questions related to Product Accessibility, Reimbursement and connecting patients to local treatment sites in their community.

Please read FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE.

September 202010US20EBC0103